Long-acting technologies
31 articles
Communities as Actors in the Research and Development Process
A publication, released by Treatment Action Group, explores the role of community engagement in health-related research and development, particularly within the Unitaid-funded LONGEVITY Project. More
Community Engagement on Microarray Patches
The growing pipeline of MAPs for various infectious diseases prevention and treatment is a cause for engagement with stakeholders involved in health care given their potential to revamp healthcare service delivery. Access useful advocacy resources! More
Long-Acting Therapies Trials Tracker for Hepatitis C, Opioid Use and Overdose Prevention Therapy, and Malaria
Treatment Action Group releases a trials tracker providing a compilation of ongoing and recently completed clinical trials on long-acting therapies for HCV, malaria, and opioid use and overdose prevention in the R&D pipeline. More
Preferences and Feasibility of Long-Acting Technologies for the Treatment of Hepatitis C - A Survey of Patients
A study explores the challenges and opportunities in long-acting HCV treatment across three LMICs: Egypt, Ethiopia and India. More
Preferences and Feasibility of Long-Acting Technologies for the Treatment of Hepatitis C - A Survey of Patients
A study explores the challenges and opportunities in long-acting HCV treatment across three LMICs: Egypt, Ethiopia and India. More
